Saturday, March 22, 2025 | 03:44 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sotac Pharmaceuticals Share Price

Know More
BSENSE
Stock not traded

128.85 6.10 (4.97%)

21-Mar-2025

BSE : 78648

NSE : SOTAC

Sector : Health care

ISIN Code : INE0O2D01012

  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Market Cap (₹ Cr)

142

Traded Value (₹ Cr)

0.12

Volume (Shares)

9,600

Face Value (₹)

10

52-Week High (₹)

202.80

52-Week High Date

15-Jul-2024

52-Week Low (₹)

87.10

52-Week Low Date

05-Jun-2024

All Time High (₹)

202.80

All Time High Date

15-Jul-2024

All Time Low (₹)

87.10

All Time Low Date

05-Jun-2024

Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act 1932 in the name of M/s Sotac Pharmaceuticals pursuant to a Deed of Partnership dated October 28 2015. Thereafter M/s. Sotac Pharmaceuticals was converted from Partnership Firm to a Private Limited Company in the name of Sotac Pharmac...
Read More

Sotac Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

142

EPS - TTM (₹) [C]

4.16

P/E Ratio (X) [C]

30.97

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [C]42.67
P/B Ratio (₹) [C]3.02

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Data Not Found

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

128.00

128.85

Year Low/High (₹)

87.10

203.00

All time Low/High (₹)

0.00

203.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week--4.17%4.26%
1 Month--2.12%2.43%
3 Month---1.46%-1.01%
6 Month---9.04%-9.46%
1 Year--5.87%6.08%
3 Year--34.23%36.41%

Company Info

Company Information

Chairman & Managing Director : Sharadkumar Dashrathbhai Patel

Whole-time Director : Dineshkumar Babulal Gelot

Executive Director : Vishalkumar Devrajbhai Patel

Executive Director : Chetankumar Bachubhai Patel

Independent Non Exe. Director : Ms. Nidhiben Patel

Independent Non Exe. Director : Hetal Umangbhai Shah

Independent Non Exe. Director : Heena Viral Patel

Registered Office: Plot No PF-21 Nr ACME Pharma, Opp Teva Pharma Sanand GIDC-II,Ahmedabad,Gujarat-382110 Ph: 91-90819 93300

Email:compliance@sotacpharma.com

URL:http://www.sotacpharma.com

FAQs about Sotac Pharmaceuticals Ltd

1. What's the Sotac Pharmaceuticals Ltd share price today?
Sotac Pharmaceuticals Ltd share price was Rs 128.85 at close on 21st Mar 2025. Sotac Pharmaceuticals Ltd share price was up by 4.97% over the previous closing price of Rs 122.75.


    2. How can I quickly analyse the performance of the Sotac Pharmaceuticals Ltd stock?
    The performance of the Sotac Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

    • The stock's PE is 30.97
    • Price to book value ratio is 3.02
    • The EPS (trailing 12 months) of the Sotac Pharmaceuticals Ltd stock is Rs 4.16


    3. What is the market cap of Sotac Pharmaceuticals Ltd?
    Sotac Pharmaceuticals Ltd has a market capitalisation of Rs 142 crore.


    4. What is Sotac Pharmaceuticals Ltd's 52-week high/low share price?
    The Sotac Pharmaceuticals Ltd’s 52-week high share price is Rs 202.80 and 52-week low share price is Rs 87.10.


    5. Is the Sotac Pharmaceuticals Ltd profitable?
    On a consolidated basis, Sotac Pharmaceuticals Ltd reported a profit of Rs 0.86 crore on a total income of Rs 18.09 crore for the quarter ended 2024. For the year ended Sep 2024, Sotac Pharmaceuticals Ltd had posted a profit of Rs 0.42 crore on a total income of Rs 27.80 crore.


    6. Which are Sotac Pharmaceuticals Ltd’s peers in the Health care sector?
    Sotac Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Hind.Bio Science, Kobo Biotech, Brawn Biotech.


    7. Who owns how much in Sotac Pharmaceuticals Ltd?
    Key changes to the Sotac Pharmaceuticals Ltd shareholding are as follows:

    • Promoter holding in Sotac Pharmaceuticals Ltd has gone up to 72.85 per cent as of Sep 2024 from 72.85 per cent as of Apr 2023.